The effect of Tagalsin on mice with transplanted H22 Hepatocarcinoma  

The effect of Tagalsin on mice with transplanted H22 Hepatocarcinoma

在线阅读下载全文

作  者:Dianguo Dong Xiuqi Song Weishan Xue Yanluo Wei 

机构地区:[1]Medical College of Qjngdao University, Qjngdao 266021, China [2]Department of Surgery, the Second Affiliated Hospital of Medical College of Ojngdao University, Ojngdao 266042, China [3]Deparment of Paediatrics, Juxian Hospital of Traditional Chinese Medicine, Rizhao 276500, China

出  处:《The Chinese-German Journal of Clinical Oncology》2011年第3期153-156,共4页中德临床肿瘤学杂志(英文版)

基  金:Supported by grants from the National "863" Scientific Item (No.2006AA09Z446);Science and Technology of Qingdao (No. 07-2-1-8-NSH-1)

摘  要:Objective: The aim of our study was to explore the inhibitory effect of Tagalsin on murine transplanted tumour and its anti-tumour mechanisms. Methods: Animal models were established by transplanting H22 hepatoma cells to the left oxter of mice, and ten days later they were randomly divided into five groups: blank control group (edible oil), positive control group (HCFU) and Tagalsin group, including low-dose, middle-dose and high-dose group. All mice were killed 24 h after medication, during which observation was conducted concerning survival conditions, body weight changes, spleen weight and tumor weight of tumor-bearing mice; the spleen index and the tumor inhibitor rate (IR) were calculated and pathological changes of tumor-bearing mice were observed by HE dye. Apoptosis factors p53 and Survivin mRNA were detected by reverse transcription polymerase chain reaction (RT-PCR). Results: Tagalsin can inhibit hepatoma growth effectively without influencing spleen index and body weight, the tumor inhibitor rate (IR) of low, middle and high dose group of Tagalsin were 15.81%, 36.75% and 74.79% respectively, the tumor inhibitor rate (IR) of HCFU were 73.93%. Apoptosis cells could be found from the specimen of the positive control group and Tagalsin groups. Reverse transcription polymerase chain reaction (RT-PCR) results showed that positive control group’s and Tagalsin treatment groups’ p53 gene expression enhanced significantly and Survivin gene expression dropped comparing with blank group (P 0.05). Conclusion: Tagalsin can inhibit growth of the H22 hepatoma cells significantly, the mechanism of anti-tumor effect may work by up-regulating p53 expression and down-regulating Survivin expression. Tagalsin may be considered as a potential candidate for chemoprevention.

关 键 词:Tagalsin H22 RT-PCR SURVIVIN p53 

分 类 号:Q78[生物学—分子生物学] S859.8[农业科学—临床兽医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象